Cryptosporidium parvum in intestinal mucosal biopsies from patients with inflammatory bowel disease [20]

American Journal of Gastroenterology

Volumn 96, Issue 12, 2001, Pages 3463-3464

  Chen, Wangxue ^a,d   Chadwick, Vinton ^a   Tie, Andrew ^b   Harp, James ^c  

^a Wakefield Gastroenterology Research Institute   (New Zealand)

^b Wellington Medical School   (New Zealand)

^c NATIONAL ANIMAL DISEASE CENTER   (United States)

^d MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROHN DISEASE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; ENTERITIS; HISTOPATHOLOGY; HUMAN; IMMUNOSTIMULATION; INTESTINE BIOPSY; LETTER; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; ULCERATIVE COLITIS;

EID: 0035662909     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)03921-1     Document Type: Letter

References (11)

1. Microbial factors in chronic intestinal inflammation
2. Protozoan parasites that infect the gastrointestinal tract
3. Cryptosporidiosis and inflammatory bowel disease. Experience from the Milwaukee outbreak
4. Cryptosporidium parvum initiates inflammatory bowel disease in germfree T cell receptor-alpha-deficient mice
5. Accelerated inflammatory bowel disease of TCR-alpha-deficient mice persistently infected with Cryptosporidium parvum
6. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment
7. 12-binding capacity and myeloperoxidase as indices of severity of acute inflammation in serial colonoscopy biopsy specimens from patients with inflammatory bowel disease
8. Detection of Listeria monocytogenes by polymerase chain reaction in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls
9. Specific PCR primers for Cryptosporidium parvum with extra high sensitivity
10. The infectivity of Cryptosporidium parvum in healthy volunteers
11. Requirements for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice